RACHEL TAYLOR: Open Payments
NPI 1396504197 · LAS VEGAS, NV. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,068 in 43 payments from 12 companies in 2025. Trend: 2023 $0 · 2024 $477 · 2025 $1,068
Food & beverage: $999Education: $69
| Company | Payments | Amount |
|---|---|---|
| UCB, Inc. | 11 | $278 |
| ABBVIE INC. | 11 | $267 |
| LEO Pharma Inc. | 7 | $140 |
| Janssen Biotech, Inc. | 3 | $122 |
| GENZYME CORPORATION | 3 | $76 |
| Lilly USA, LLC | 2 | $56 |
| E.R. Squibb & Sons, L.L.C. | 1 | $32 |
| Botanix SB Inc | 1 | $28 |
| Solta Medical, a division of Bausch Health US, LLC | 1 | $22 |
| Novartis Pharmaceuticals Corporation | 1 | $16 |
Products named: Bimzelx, SKYRIZI, ADBRY, TREMFYA, DUPIXENT, EBGLYSS, Sotyktu, SOFDRA.
Industry payments across NV — which companies pay providers there.
